OTCMKTS:AIMD Ainos (AIMD) Stock Price, News & Analysis → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free AIMD Stock Alerts $1.03 -0.01 (-0.96%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$1.01▼$1.0450-Day Range$0.81▼$2.0552-Week Range$0.79▼$6.10Volume9,887 shsAverage Volume1.62 million shsMarket Capitalization$6.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC Filings Get Ainos alerts: Email Address Ad Paradigm PressAI “wealth window” is closing soon!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… About Ainos Stock (OTCMKTS:AIMD)Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Read More AIMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AIMD Stock News HeadlinesApril 10, 2024 | americanbankingnews.comAinos (OTCMKTS:AIMD) Stock Price Down 11.1%March 11, 2024 | msn.comSOS, MFG and LYT among pre-market losersApril 18, 2024 | Darwin (Ad)Your Next Portfolio Star: Revealing 2024's Top Stock Pick We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)March 10, 2024 | finance.yahoo.comAinos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)March 8, 2024 | finanznachrichten.deAinos, Inc.: Ainos Reports Full Year 2023 Financial ResultsMarch 8, 2024 | markets.businessinsider.comNasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In FebruaryMarch 4, 2024 | edition.cnn.comAinos IncFebruary 23, 2024 | benzinga.comAinos Stock (NASDAQ:AIMD), Short Interest ReportApril 18, 2024 | Darwin (Ad)Your Next Portfolio Star: Revealing 2024's Top Stock Pick We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)February 8, 2024 | finance.yahoo.comSmall-Cap Growth Virtual Investor Conference Presentations Now Available for Online ViewingFebruary 1, 2024 | finance.yahoo.comAinos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7thJanuary 5, 2024 | msn.comUS Stocks Higher; Payrolls Increase By 216,000 In DecemberJanuary 5, 2024 | investorplace.comWhy Is Ainos (AIMD) Stock Up 157% Today?January 2, 2024 | finanznachrichten.deAinos, Inc.: Ainos Regains Compliance with Nasdaq Minimum Bid Price RequirementJanuary 2, 2024 | finance.yahoo.comAinos Regains Compliance with Nasdaq Minimum Bid Price RequirementDecember 26, 2023 | finance.yahoo.comAinos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of SmellDecember 12, 2023 | msn.comAinos implements a reverse stock splitDecember 12, 2023 | finance.yahoo.comAinos, Inc. Announces Stock ConsolidationNovember 28, 2023 | finance.yahoo.comAinos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss PharmaceuticalNovember 10, 2023 | msn.comAinos GAAP EPS of -$0.15November 9, 2023 | finance.yahoo.comAinos Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | morningstar.comAinos Inc AIMDNovember 6, 2023 | finance.yahoo.comAinos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONASeptember 25, 2023 | finance.yahoo.comAinos Announces Placement of Initial $3 Million Tranche of $10 Million Private PlacementSeptember 19, 2023 | finance.yahoo.comWith Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV PatientsSeptember 18, 2023 | finanznachrichten.deAinos, Inc.: Ainos' VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSeptember 18, 2023 | finance.yahoo.comAinos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSee More Headlines Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:AIMD CUSIPN/A CIK1014763 Webwww.amarbio.com Phone(858) 869-2986Fax806-376-9301Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,010,000.00 Net Margins-515.80% Pretax Margin-515.76% Return on Equity-44.32% Return on Assets-40.35% Debt Debt-to-Equity Ratio0.08 Current Ratio1.92 Quick Ratio1.45 Sales & Book Value Annual Sales$122,112.00 Price / Sales51.82 Cash FlowN/A Price / Cash FlowN/A Book Value$1.50 per share Price / Book0.69Miscellaneous Outstanding Shares6,144,000Free Float13,322,000Market Cap$6.33 million OptionableNot Optionable Beta1.44 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Chun-Hsien Tsai (Age 54)Chairman of Board, President & CEO Comp: $112.12kMr. Lawrence Kennedy Lin (Age 55)Executive Vice President of Operations Comp: $144kKey CompetitorsBIOLASENASDAQ:BIOLIntelligent Bio SolutionsNASDAQ:INBSVapothermNYSE:VAPOProSomnusNASDAQ:OSAReShape LifesciencesNASDAQ:RSLSView All CompetitorsInsidersTing-Chuan LeeBought 61,157 shares on 4/26/2023Total: $48,314.03 ($0.79/share)Ainos IncSold 400,000 sharesTotal: $300,000.00 ($0.75/share) AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed in 2024? Ainos' stock was trading at $2.05 at the start of the year. Since then, AIMD shares have decreased by 49.8% and is now trading at $1.03. View the best growth stocks for 2024 here. When did Ainos' stock split? Ainos's stock reverse split before market open on Tuesday, August 9th 2022. The 1-15 reverse split was announced on Tuesday, August 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AIMD) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.